A study of 2,500 youth links high sedentary time to a 4 mmHg rise in systolic blood pressure by adulthood, while light ...

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, ...

Time spent sedentary beyond six hours per day during growth from childhood through young adulthood may cause an excess increase of 4 mmHg in systolic ...

Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the third quarter ended September 30, 2024. Leap ...

Around half of NSCLC patients experience severe muscle wasting, known as cachexia, which limits treatment options and worsens prognosis. The research involved a cohort of 55 patients with metastatic ...

NEW YORK, Nov. 12, 2024 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global Glaucoma Therapeutics Market is experiencing significant growth owing to the ...

NORTHBROOK, Ill., Nov. 12, 2024 /PRNewswire/ -- Endevica Bio's experimental peptide to prevent weight loss associated with ...

Currently, there is no FDA-approved treatment for cancer anorexia cachexia syndrome. ART26.12, Artelo's lead Fatty Acid ...

Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...

Ponsegromab increased weight and activity levels in cachexia patients, confirming GDF-15 as a key driver and therapeutic ...

Nov. 12, 2024 — Researchers have found that the way DNA is packaged in cells can directly impact how fast DNA itself is copied during cell division. They discovered that DNA packaging sends ...

Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with ...